PPARα LBD (human recombinant)

Product Description

Stability : 6 months
Formulation :
A solution in 50 mM sodium phosphate, pH 7.2, containing 20% glycerol, 100 mM sodium chloride, and 1 mM DTT
Description :
PPARα is highly expressed in tissues displaying a high catabolic rate of fatty acids such as the liver, skeletal muscles, brown fat, heart, kidneys, and cells of artherosclerotic lesions.  Fatty acids, NSAIDs, prostaglandins, leukotriene B4, WY 14643, and hypolipidemic drugs are PPARα ligands. PPARα transcriptionally regulates a variety of genes involved in fatty acid metabolism and oxidation, such as acyl-CoA oxidase, enol-CoA hydratase, medium chain fatty acyl-CoA dehydrogenase, fatty acid transport protein, and cytochrome P450 4A isozymes.
Purity : >90%
Storage : -80°C

Disclaimer: the information on this website is from the internet for reference only. Please refer to the actual instructions attached to the product and the final interpretation is owned by the company.

Send inquiry online For more product information and prices

(Pharmaceutical Ingredients Manufacturer & Supplier & Exporter.)

After sending the online inquiry, we will reply you as soon as possible, if not get any response on time please contact us by Tel or Email. —— Green Stone Swiss

Email: sales@raw-pharmaceutical-materials.com
Tel: +86 592 5365887
WhatsApp: +86 189 6515 7632
Send inquiry online: